Variable | MIS-C Patients | SCNS Patients | P Value |
---|---|---|---|
Age (yrs), median (IQR) | 12.0 (10.0–13.0) | 12.5 (11.0-13.2) | 0.617 |
Male sex, no. (%) | 11 (91.7) | 11 (91.7) | 1.000 |
Weight (kg), median (IQR) | 49.0 (36.7–57.5) | 35.4 (31.8–48.7) | 0.326 |
Clinical Measures, median (IQR) | Â | Â | Â |
PRISM III Score | 5.5 (2.8–7.3) | 6.5 (2.2–13.8) | 0.663 |
PIM2 Mortality Risk | 1.2 (1.0-4.4) | -3.4 (-4.3–2.8) | < 0.001 |
dPELOD Initial | 1 (0.0–3.0) | 10.5 (0.0–12.0) | 0.063 |
sPELOD Score Highest | 2.5 (0.8–3.2) | 12.0 (11.0-12.5) | < 0.001 |
GCS Admission | 15.0 (15.0–15.0) | 14.0 (7.0–15.0) | 0.007 |
Source of Infection, no. (%) | Â | Â | Â |
Respiratory | 12 (100.0) | 8 (66.7) | 0.093 |
Cardiovascular | 0 (0) | 2 (16.7) | 0.478 |
Gastrointestinal | 0 (0) | 1 (8.3) | 1.000 |
Wound | 0 (0) | 1 (8.3) | 1.000 |
Pathogen Type, no. (%) | Â | Â | Â |
Bacteria - Gram positive | 0 (0) | 2 (16.7) | 0.478 |
Bacteria - Gram negative | 0 (0) | 6 (50.0) | 0.014 |
Viral1/Bacteria Gram positive | 0 (0) | 1 (8.3) | 1.000 |
Viral postive1 | 0 (0) | 3 (25.0) | 0.217 |
SARS-CoV-2 positive | 12 (100) | 0 (0) | < 0.001 |
Ventilation, no. (%) | Â | Â | Â |
Invasive Ventilation | 2 (16.7) | 6 (50.0) | 0.192 |
Non-Invasive Ventilation | 2 (16.7) | 2 (16.7) | 1.000 |
Hemodynamic Support, no. (%) | Â | Â | Â |
Inotrope/Vasopressors | 8 (66.7) | 10 (83.3) | 0.640 |
Outcomes, median (IQR) | Â | Â | Â |
Alive, no. (%) | 12 (100.0) | 12 (100.0) | 1.000 |
PICU length of stay | 5.5 (2.0-7.5) | 5.5 (2.8–10.2) | 0.706 |
Hospital length of stay | 8.0 (5.8–10.5) | 12.5 (9.5–16.8) | 0.040 |